"Desmoglein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS VULGARIS.
| Descriptor ID |
D051184
|
| MeSH Number(s) |
D12.776.395.550.200.200.500.500.750 D12.776.543.550.200.200.500.500.750 D23.050.301.350.200.500.500.750 D23.050.422.249
|
| Concept/Terms |
Desmoglein 3- Desmoglein 3
- Desmosomal Glycoprotein 3
- Desmoglein III
|
Below are MeSH descriptors whose meaning is more general than "Desmoglein 3".
Below are MeSH descriptors whose meaning is more specific than "Desmoglein 3".
This graph shows the total number of publications written about "Desmoglein 3" by people in this website by year, and whether "Desmoglein 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Desmoglein 3" by people in Profiles.
-
Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease. Cell Rep. 2019 07 23; 28(4):909-922.e6.
-
Comparison of ethylenediaminetetraacetic acid-treated desmoglein ELISA and conventional desmoglein ELISA in the evaluation of pemphigus vulgaris in remission. J Am Acad Dermatol. 2018 Oct; 79(4):768-770.
-
Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review. Int Immunopharmacol. 2018 Jan; 54:131-138.
-
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol. 2017 May; 76(5):889-894.e5.